Discipline, Enforcement, and Professional Ethics
Discipline items test the statutory grounds, the Board's process, and the ethical duties that generate complaints in the first place.
Grounds
The Board may act for violation of pharmacy law or rule, violation of federal drug law, unprofessional conduct, negligence or incompetence, fraud or deceit in obtaining a license or in records, dispensing without a valid prescription, practicing while impaired, aiding unlicensed practice, and disciplinary action taken in another jurisdiction. A criminal conviction related to the practice supports discipline, and the same conduct can produce parallel DEA and Board actions.
Process
A complaint goes to DORA's investigation unit; the Board reviews and may dismiss, issue a non-disciplinary letter of concern, negotiate a stipulation, or file formal charges. A hearing is conducted before an administrative law judge, and the Board issues the final order. Available sanctions include reprimand, probation with monitoring and work restrictions, suspension, revocation, fines, and required continuing education. The Board may summarily suspend when continued practice poses an imminent threat to public health. Unlicensed practice is addressed through cease-and-desist orders and referrals.
Reporting duties
Licensees must report certain events-such as discipline in another state or a conviction-within the time set by rule. Practitioners have an ethical and often legal duty to report impaired colleagues and to protect patients, balanced against confidentiality.
Ethics
Core expectations: protect patient confidentiality under HIPAA and state law, avoid conflicts such as industry gifts that influence prescribing, never falsify records or inventory, obtain informed consent, avoid abandoning patients, and keep professional boundaries. Social media posts must not contain protected health information.
Worked example
A pharmacist removes small quantities of oxycodone from stock over several weeks and adjusts inventory counts to conceal it. This implicates diversion, falsification, and unprofessional conduct; the pharmacy reports the theft to DEA and the Board, the pharmacist's access is removed, and the Board pursues suspension with monitoring while a criminal referral proceeds. A letter of concern would be inadequate given the risk to the public.
Traps
- Treating a letter of concern as discipline.
- Missing a required self-report.
- Assuming another state's discipline has no Colorado consequence.
- Believing a DEA action resolves the Board matter.
- Failing to document patient-protection steps after an impairment report.